DR. HUGH VANLANDINGHAM M.D. NPI 1326056706

NPI Details

DR. Hugh Vanlandingham, M.D. is a family medicine in Tallahassee, FL with 26 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Hugh Vanlandingham, M.D. NPI is 1326056706. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1999

The provider's business location address is:

1511 SURGEONS DR
TALLAHASSEE, FL
ZIP 32308-632
Phone: (850) 878-6134

The NPI 1326056706 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home (HCPCS:M0201)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Hemoglobin a1c level (HCPCS:83036)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Automated urinalysis test (HCPCS:81003)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urinalysis, manual test (HCPCS:81002)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Urine microalbumin (protein) level (HCPCS:82043)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Vitamin d-3 level (HCPCS:82306)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Removal of impacted ear wax (HCPCS:69210)
• Uric acid level, blood (HCPCS:84550)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Red blood count, manual test (HCPCS:85044)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)

The enumeration date for this NPI number is 8/3/2006 and was last updated on 4/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.